APA ציטוט

Erba, H. P., Becker, P. S., Shami, P. J., Grunwald, M. R., Flesher, D. L., Zhu, M., . . . Wang, E. S. (2019). Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia. Blood Adv.

Citação norma Chicago

Erba, Harry P., et al. "Phase 1b Study of the MDM2 Inhibitor AMG 232 With or Without Trametinib in Relapsed/refractory Acute Myeloid Leukemia." Blood Adv 2019.

ציטוט MLA

Erba, Harry P., et al. "Phase 1b Study of the MDM2 Inhibitor AMG 232 With or Without Trametinib in Relapsed/refractory Acute Myeloid Leukemia." Blood Adv 2019.